France's Servier finally goes on trial over Mediator safety ...

More than a decade after a scandal over drug safety in France first broke, the pharma company Servier is to go on trial over its weight loss drug Mediator, which is thought to have caused b

Purdue preps bankruptcy as opioid settlement bid stumbles; r...

Novo Nordisk faces $1.8 billion lawsuit over US insulin sale...

Novo Nordisk is facing a lawsuit from disgruntled investors seeking around $1.8 billion in compensation, saying the company failed to properly update the market about the situation regardin

Facing opioid liability risk, Mallinckrodt stalls generics s...

German court blocks Sanofi's cholesterol drug after Amgen la...

Amgen has lived up to its litigious reputation after it successfully persuaded a German court to uphold a patent blocking Sanofi from marketing its rival injected cholesterol drug in the co

Gilead faces lawsuit over HIV drug pricing

Gilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving HIV drugs from entering the market.